The overall stock score is significantly impacted by the company's critical financial condition, characterized by high leverage, negative equity, and cash flow problems. Technical analysis provides a slight positive offset with some short-term momentum, while valuation metrics reinforce concerns due to negative earnings and the lack of dividends.

Greenrise Global Brands Inc (XCX) vs. iShares MSCI Canada ETF (EWC)

Market Cap

C$516.55K

Dividend YieldN/A

Average Volume (3M)1.88K

Price to Earnings (P/E)―

Beta (1Y)-5.36

Revenue GrowthN/A

EPS GrowthN/A

CountryCA

Employees200

SectorHealthcare

Sector Strength42

IndustryDrug Manufacturers - Specialty & Generic

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding51,655,370

10 Day Avg. Volume1,100

30 Day Avg. Volume1,883

Financial Highlights & Ratios

PEG Ratio0.02

Price to Book (P/B)-1.21

Price to Sales (P/S)0.00

P/FCF Ratio-2.60

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

Greenrise Global Brands Inc Business Overview & Revenue Model

Company DescriptionGreenrise Global Brands Inc (XCX) is a company operating in the wellness and health sectors, focusing primarily on the development, distribution, and marketing of cannabis and hemp-derived products. The company is committed to providing high-quality, sustainable, and innovative products that cater to a wide range of consumer needs, including medicinal and recreational uses.

How the Company Makes MoneyGreenrise Global Brands Inc generates revenue primarily through the sale of its cannabis and hemp-based products. These products are sold through various channels, including direct-to-consumer sales, retail partnerships, and online platforms. The company may also engage in wholesale distribution to other businesses and maintain strategic partnerships with retailers and distributors to expand its market reach. Additional revenue streams can include licensing agreements for their proprietary strains or technologies. Collaboration with research institutions for product development can also contribute to its earnings, along with any ancillary services related to the cannabis industry.

Greenrise Global Brands Inc Financial Statement Overview

Summary

The company is facing severe financial difficulties with no revenue generation and significant losses. It is highly leveraged with negative equity, indicating potential insolvency risks. Cash flow issues are prominent, with consistently negative free cash flow.

Income Statement

Very Negative

The company has shown no revenue in the TTM period and previous years, indicating severe challenges in generating sales. The net income remains negative, and the EBIT and EBITDA are also negative, reflecting operational inefficiencies and substantial losses.

Balance Sheet

Very Negative

The balance sheet reflects a highly leveraged position with a negative stockholders' equity, indicating insolvency risk. The debt-to-equity ratio is extremely high, suggesting financial instability. Additionally, the company has negative equity, which is a significant red flag.

Cash Flow

Very Negative

The company consistently generates negative free cash flow, which has deteriorated further in the TTM period. The operating cash flow is negative, and the free cash flow to net income ratio is undefined due to negative earnings, indicating liquidity issues and poor cash generation.

Breakdown	TTM	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Income Statement
Total Revenue	0.00	0.00	0.00	452.87K	105.20K	0.00
Gross Profit	0.00	0.00	0.00	43.32K	-153.00	0.00
EBITDA	13.43K	―	-561.08K	-2.23M	-1.98M	0.00
Net Income	-155.96K	―	-2.32M	-3.78M	-2.16M	―
Balance Sheet
Total Assets	443.25K	441.82K	1.25M	252.94K	371.56K	547.98K
Cash, Cash Equivalents and Short-Term Investments	17.19K	31.53K	-619.68K	27.45K	60.45K	242.86K
Total Debt	3.04M	2.80M	3.15M	1.90M	1.08M	366.53K
Total Liabilities	3.18M	3.06M	3.56M	2.26M	1.34M	639.12K
Stockholders Equity	-2.74M	-2.61M	-2.32M	-2.00M	-972.61K	―
Cash Flow
Free Cash Flow	-185.21K	199.35K	-1.08M	-1.95M	-1.88M	―
Operating Cash Flow	-185.21K	199.35K	-1.08M	-1.89M	-1.83M	―
Investing Cash Flow	50.40K	387.50K	-531.00K	-63.15K	45.43K	543.70K
Financing Cash Flow	110.00K	-534.73K	1.51M	1.92M	1.63M	1.22M

Greenrise Global Brands Inc Peers Comparison

Overall Rating

UnderperformOutperform

Sector (46)

Financial Indicators

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
OGI	71 Outperform	$246.35M	17.68	4.76%	―	26.93%	―
CURA	54 Neutral	$833.09M	―	-25.08%	―	-0.11%	11.22%
ACB	50 Neutral	$321.17M	97.94	3.05%	―	16.39%	-98.10%
WEED	47 Neutral	$350.96M	―	-122.10%	―	-16.27%	―
Sector *	46 Neutral	C$190.36M	-4.25	-8.56%	3.09%	13.53%	-1.76%
XCX	23 Underperform	C$516.55K	―	5.70%	―	―	―

* Healthcare Sector Average

Performance Comparison

TSE:XCX

Greenrise Global Brands Inc

0.01

0.00

0.00%

TSE:WEED

Canopy Growth

1.69

-6.87

-80.26%

TSE:ACB

Aurora Cannabis

5.71

-0.47

-7.61%

TSE:OGI

OrganiGram Holdings

1.84

-0.22

-10.68%

TSE:CURA

Curaleaf Holdings

1.10

-4.05

-78.64%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 14, 2025